<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA: Amyotrophic Lateral Sclerosis Topic Collection</title>
    <link>http://jama.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Sat, 01 Dec 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:44:01 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@jama.jamanetwork.com</managingEditor>
    <webMaster>webmaster@jama.jamanetwork.com</webMaster>
    <item>
      <title>Potential Target for ALS Therapy</title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=1367458</link>
      <pubDate>Wed, 03 Oct 2012 00:00:00 GMT</pubDate>
      <author>Hampton T. </author>
      <description>&lt;span class="paragraphSection"&gt;Expression of EPHA4, a receptor previously shown to influence axon growth, was inversely correlated with late disease onset and survival in 158 Dutch patients with amyotrophic lateral sclerosis (ALS), report investigators from Belgium (Van Hoecke A et al. Nat Med. doi:10.1038/nm.2901 [published online August 26, 2012]). EPHA4 binds to ephrins, proteins thought to play a role in synapse formation and regulation of long-term synaptic plasticity and memory.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">308</prism:volume>
      <prism:number xmlns:prism="prism">13</prism:number>
      <prism:startingPage xmlns:prism="prism">1310</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1310</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2012.13154</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=1367458</guid>
    </item>
  </channel>
</rss>